Last updated: 2026-09-12 17:08:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Boston Scientific Corp. (BSX) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $42,96, with a market capitalization of $62,46B and a P/E ratio of 16,95. Over the past 52 weeks, its price has ranged from $42,20 to $105,65. This page covers its latest market performance, valuation, price trends and company information.
$62,46B | |
$43,19 | |
$109,50 | |
$4,79 | |
$43,10 | |
21,17M | |
20,12M | |
16,95 | |
$105,65 | |
$42,20 | |
-- | |
-- |
Boston Scientific Corp. (BSX) last closed at $43,10 as of 2026-09-12 00:00:00, unchanged from the previous close of $43,10.
During the latest regular trading session, BSX traded between $4,79 and $109,50, with a volume of 21,17M shares. The closing price was near the middle and near the lower end of its 52-week range.
Over the past seven days, Boston Scientific Corp. (BSX) moved from $48,37 to $42,96, representing a decline of 11,18% ($5,41).
The stock traded between $42,78 and $49,66 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 21,28 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 1,2%
BSX is currently trading at $42,96, placing it 1,2% of the way from its 52-week low of $42,20 to its 52-week high of $105,65. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 59000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Boston Scientific Corp. (BSX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.